Our Medication Webinars:

Feeling overwhelmed by all the new recently approved diabetes medications? We have multiple webinars to help you stay up to date on medication guidelines and management.

Meds Management Update – 1.5 CEs for $29

Are you wondering how to apply the 2021 American Diabetes Association (ADA) Management of Hyperglycemia Guidelines into practice? 

Join Beverly to gain insight into the increasingly complex world of diabetes medications and management. This webinar will discuss how to integrate these new medication recommendations into our practice. We will discuss the benefits, considerations and critical information to share with our patients and providers.

• Overview of classes and actions of diabetes medications
• Medication management updates and new recommendations
• Using the ADA algorithms to improve diabetes care and outcomes

---

Diabetes Medications Articles and Standards

ADA Standards of Care – This yearly publication by the American Diabetes Association outlines the national goals of care based on the latest research for diabetes management. This is one of the most important guidelines to read as a Certified Diabetes Care and Education Specialist

Purchase ADA Standards of Care 2021 Booklet

Screening and Diagnosis of Diabetes Mellitus 2021 – One-page cheat sheet that summarizes screening, risk status, and diagnostic criteria for diabetes. Great for your office and as a study tool.

Pharmacologic Approaches to Glycemic Treatment in 2021.  This hyperglycemia road map details strategies to achieve glucose control for both Type 1 and Type 2 Diabetes. Section 8 of Standards of Care, 2020

Med Cheat Sheets 2021 | Hypertension, Lipids, and Neuropathy These summary sheets are helpful for your clinical practice and preparing for certification exams. For exam success, be familiar with the general concepts, (side effects and precautions) of these medications.

Management of Hyperglycemia in Type 2 Diabetes, 2019. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

AACE 2020 Diabetes Management Algorithms Slide Summary A slide set summary of the ACE/AACE Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus.  Encourage all those planning to take CDCES exam to review this info carefully.

AADE – White Paper on Continuous Subcutaneous Insulin Therapy 2018 » This paper outlines the topics that should be covered by diabetes educators when teaching patients and families or significant others about insulin pump therapy.  

Diabetes Meds on a Budget – 2017 » This article by Beverly Thomassian, provides practical and affordable strategies to manage hyperglycemia when funds are limited.

---

AADE – Strategies for InsulinTherapy 2011.PDF » An excellent review of the latest research on proper insulin administration techniques, patient barriers, and insulin therapy.

Beyond Metformin: Safety Considerations in the Decision Making Process for Selecting a Second Medication for Type 2 Diabetes Management » This expert opinion article outlines the latest data on the safety and other considerations for currently available medications to treat type 2 diabetes. Published in Diabetes Care, 2014.

---

Concentrated Insulins

Glargine (Toujeo) Concentrated Glargine insulin 300units/mL package insert
Glargine (Toujeo) Patient Teaching Handout

U-500 Insulin Package Insert – 2016

An overview of concentrated Insulin Products – 2016

---

Insulin Pump Articles

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial
Efficacy of Insulin Pump Therapy in Elderly Patients
Tandem Diabetes Care Press Release for T:flex Insulin Pump

---

Inhaled Insulin Articles

Inhaled Insulin – Afrezza – Package Insert
Inhaled Insulin – Afrezza – Patient Medication Guide

---

Medication Updates

Challenges with Insulin in the Inpatient Setting – 2016

Future of biosimilar insulins – 2016

Basal-insulin-with-glp-1-receptor-agonists – 2016

Insulin deglude/liraglutide (IDegLira) for the treatment of type 2 Diabetes – 2016

Iglarlixi – review of findings (technical paper)Novel Agents for the Treatment of Type 2 – 2014 – Diabetes Spectrum » Recent innovative treatment approaches target the multiple pathophysiological defects present in type 2 diabetes. Optimal management should include early initiation of combination therapy using multiple drugs with different mechanisms of action. This review examines novel therapeutic options that hold particular promise.   Metformin and B12 Deficiency » This complication affects about 30% of patients with diabetes who take metformin. Despite its common occurrence, vitamin B12 deficiency is often unrecognized and untreated. For this reason, patients on metformin should have their B12 level monitored annually. Published in BMJ. 2010;340:c2198Origin Trial – NEJM 2012 – Outcome Reduction with an Initial Glargine Intervention » This large randomized prospective trial followed patients with prediabetes and diabetes who were on daily doses of basal insulin for 6 years. The study demonstrated that Lantus therapy had a neutral effect on cardiovascular outcomes and cancers.  And it reduced new onset diabetes in those with prediabetes.

---

Medications for Neuropathy

Painful Diabetic Neuropathy » scientific article that includes the latest research and medications that improve neuropathic pain. Also includes a step wise approach and dosing strategies for the different types of medications. Authored by Dr. Ziegler, Diabetes Care, 2009 32 (Supp 2).Neuropathy Medications Summary Sheet » this “at a glance” summary page is designed to be a helpful tool to evaluate therapeutic improvements for your patients with diabetes neuropathy.  Authored by Beverly Thomassian.

---